ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 603071 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 603071; 2) Community: the network communities that were significantly associated with the response to NSC 603071; 3) Molecule: the relationships between components within communities and NSC 603071; 4) MDR: the compounds that were significantly associated with the NSC 603071.

NSC Compound Enrichment Correlation
NSC 734799 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.0135588245836371 0.68800963
NSC 105132 Deoxycamptothecin 0.0137891122538509 0.88113718
NSC 107392 5-HP 0.0137891122538509 0.65796553
NSC 132275 Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) 0.0137891122538509 0.31743134
NSC 134723 K 31 0.0137891122538509 0.56515472
NSC 295499 Camptothecin Derivative 0.0137891122538509 0.84532824
NSC 48890 Null 0.0137891122538509 0.37539863
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0137891122538509 0.034438648
NSC 625603 Null 0.013789112253851 0.25830727
NSC 684667 Null 0.013789112253851 0.5293503
Total:61  Current:22    [First] [Prev] [Next] [Last]